Dina M. Sakaeva

Ufa, BA, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Whole Exome Sequencing Study Suggests an Impact of FANCA, CDH1 and VEGFA Genes on Diffuse Gastric Cancer Development.

Whole Exome Sequencing Study Suggests an Impact of FANCA, CDH1 and VEGFA Genes on Diffuse Gastric Cancer Development.

Journal: Genes

Published: October 03, 2022

The Burden of Residual SymptOms That Complicate the Life of Patients Who Have Suffered a new Coronavirus Infection (THROW study).

The Burden of Residual SymptOms That Complicate the Life of Patients Who Have Suffered a new Coronavirus Infection (THROW study).

Journal: Kardiologiia

Published: June 08, 2022

Novel PD-1 inhibitor prolgolimab: expanding non-resectable/metastatic melanoma therapy choice.

Novel PD-1 inhibitor prolgolimab: expanding non-resectable/metastatic melanoma therapy choice.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 23, 2020

Targeted next-generation sequencing of 21 candidate genes in hereditary ovarian cancer patients from the Republic of Bashkortostan.

Targeted next-generation sequencing of 21 candidate genes in hereditary ovarian cancer patients from the Republic of Bashkortostan.

Journal: Journal of ovarian research

Published: September 04, 2020

Efficacy and Safety of Trastuzumab Emtansine Plus Capecitabine vs Trastuzumab Emtansine Alone in Patients With Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer: A Phase 1 and Randomized Phase 2 Trial.

Efficacy and Safety of Trastuzumab Emtansine Plus Capecitabine vs Trastuzumab Emtansine Alone in Patients With Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer: A Phase 1 and Randomized Phase 2 Trial.

Journal: JAMA oncology

Published: June 26, 2020

Lynch Syndrome Germline Mutations in Breast Cancer: Next Generation Sequencing Case-Control Study of 1,263 Participants.

Lynch Syndrome Germline Mutations in Breast Cancer: Next Generation Sequencing Case-Control Study of 1,263 Participants.

Journal: Frontiers in oncology

Published: November 02, 2019

Randomised phase III trial of vinflunine plus capecitabine versus capecitabine alone in patients with advanced breast cancer previously treated with an anthracycline and resistant to taxane.

Randomised phase III trial of vinflunine plus capecitabine versus capecitabine alone in patients with advanced breast cancer previously treated with an anthracycline and resistant to taxane.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: February 16, 2018

Five-year Survival of Patients With Metastatic Renal Cell Carcinoma in the Russian Federation: Results From the RENSUR5 Registry.

Five-year Survival of Patients With Metastatic Renal Cell Carcinoma in the Russian Federation: Results From the RENSUR5 Registry.

Journal: Clinical genitourinary cancer

Published: April 27, 2017

The search for new candidate genes involved in ovarian cancer pathogenesis by exome sequencing

The search for new candidate genes involved in ovarian cancer pathogenesis by exome sequencing

Journal: Genetika

Published: October 01, 2016

The immunosuppressive microenvironment of malignant gliomas

The immunosuppressive microenvironment of malignant gliomas

Journal: Arkhiv patologii

Published: February 05, 2016

A Phase II Biomarker-Embedded Study of Lapatinib plus Capecitabine as First-line Therapy in Patients with Advanced or Metastatic Gastric Cancer.

A Phase II Biomarker-Embedded Study of Lapatinib plus Capecitabine as First-line Therapy in Patients with Advanced or Metastatic Gastric Cancer.

Journal: Molecular cancer therapeutics

Published: November 11, 2015

Gene disorders and molecular genetic subtypes of malignant gliomas

Gene disorders and molecular genetic subtypes of malignant gliomas

Journal: Arkhiv patologii

Published: September 07, 2013

Showing 1-12 of 14

Last Updated: 09/26/2026